Nano Labs Announces Resignation of Dr. Victor Castano
March 05 2014 - 6:18PM
Marketwired
Nano Labs Announces Resignation of Dr. Victor Castano
DETROIT, MI--(Marketwired - Mar 5, 2014) - Nano Labs Corp.
(OTCQB: CTLE) announces that Dr. Victor Castano has resigned as
Chairman, Member of the Board of Directors, and Chief
Technology Officer of Nano Labs Corporation for personal
reasons, effective March 4, 2014.
Nano Labs thanks Dr. Castano for his contributions to the
Company and wishes him well with his future endeavors. Dr. Victor
Castano's resignation is not the result of any disagreement with
the Company on any matter relating to its operation, policies
(including accounting or financial policies) or practices. Pursuant
to Dr. Castano's resignation, he acknowledges that he does not have
any claims against the Company upon his resignation.
The Board of Directors hereby ratifies, confirms and appoints
Bernardo Camacho Chavarria as the Chairman of the Board of
Directors. The company intends to appoint a new Chief Research and
Development Officer in the near future, with several candidates
already under review.
The company intends to further update shareholders in the coming
days.
Respectfully on behalf of the Board,
Mr. Bernardo Camacho Chavarria President, Nano Labs
About Nano Labs Nano Labs Corp. (CTLE) is a nanotechnology
company whose research and development team of scientists,
designers, and engineers is focused on creating a portfolio of
advanced products that could provide benefits to a variety of
industries including: (i) consumer products, (ii) energy, (iii)
materials, and (iv) healthcare. Through the use and integration of
proprietary nano compounds, our goal is to evolve common products
into new, revolutionary products in order to make the world a
better place. Nano Labs shares are traded on the OTC Bulletin Board
in the United States under the ticker CTLE. For more information,
please visit www.NanoLabs.us.
Forward-looking statements This press release contains
forward-looking information within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1993 and Section 21E of the Securities Exchange
Act of 1934 and is subject to the safe harbor created by those
laws. These forward-looking statements are based upon a number of
assumptions and estimates that are subject to significant
uncertainties that involve known and unknown risks, many of which
are beyond our control and are not guarantees of future
performance. Actual outcomes and results could materially differ
from what is expressed, implied, or forecasted in any such
forward-looking statements and any such difference may be caused by
risk factors listed from time to time in the Company's news
releases and/or its filings with the OTC Bulletin Board or as a
result of other factors.
Contact: Bernardo Camacho Chavarria President 1 (888)
806-2315